Artal Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-67,909
| Closed | -$566K | – | 119 |
|
|
2023
Q1 | $566K | Buy |
+67,909
| New | +$566K | 0.03% | 100 |
|
|
2018
Q1 | – | Sell |
-500,000
| Closed | -$2.46M | – | 87 |
|
|
2017
Q4 | $2.46M | Sell |
500,000
-150,000
| -23% | -$737K | 0.04% | 57 |
|
|
2017
Q3 | $3.41M | Sell |
650,000
-200,000
| -24% | -$1.05M | 0.06% | 50 |
|
|
2017
Q2 | $4.73M | Buy |
850,000
+350,000
| +70% | +$1.95M | 0.08% | 41 |
|
|
2017
Q1 | $4.2M | Buy |
+500,000
| New | +$4.2M | 0.09% | 45 |
|